Efficacy and Safety of Semaglutide 7.2 mg in Obesity: The STEP UP Trial
Authors:
Sean Wharton1,2; Paula Freitas3,4; Jøran Hjelmesaeth5,6; Maria Kabisch7; Kristian Kandler8; Ildiko Lingvay9; Maria De Los Angeles Quiroga Pelaez7; Julio Rosenstock10; W. Timothy Garvey11
Affiliations
View DetailsHide Details
{{ getPageNum(PDFPage) }}
Download poster (.pdf)
Share
Copy link
{{pageUrl}}
Keywords
Obesity
Congress poster
GLP-1 RA
Semaglutide
PHASE 3 (RCT)
Get notified when materials for ADA 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
Get notified when materials for ADA 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
{{ error.$message }}
Success
We will notify you when new materials become available for ADA 2025 and future congresses.
We will keep you updated in your inbox:
Subscribe to receive updates on related congresses in the same disease area: